Bioharvest Sciences Inc.
BHST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723464
No open-market purchases or sales by Bioharvest Sciences Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $4.80M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Bioharvest Sciences Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 22 | 20 | −2 |
| Shares | 1.63M | 1.70M | +67.5K (+4.1%) |
| Value | $8.48M | $7.38M | −$1.10M (−12.9%) |
New holders (2)
Institutions that held Bioharvest Sciences Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Silverberg Bernstein Capital Management LLC | 26,099 | $113.3K | 0.06% |
| Vident Advisory, LLC | 11,576 | $50.2K | 0.00% |
Sold out (4)
Institutions that held Bioharvest Sciences Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Quadrature Capital Ltd | 27,065 | $140.5K |
| Marshall Wace, LLP | 21,235 | $110.2K |
| HRT Financial LP | 14,632 | $75.0K |
| Virtu Financial LLC | 11,556 | $60.0K |